Sulfadoxine Export Market Intelligence: India's 41 Suppliers Shipping to 38 Countries — TransData Nexus 2026

Q: Who are the top sulfadoxine exporters from India?

The top sulfadoxine exporters from India are: 1. S KANT HEALTHCARE LIMITED — $37.5M (69.5% market share); 2. MACLEODS PHARMACEUTICALS LTD — $4.0M (7.4% market share); 3. GRACURE PHARMACEUTICALS LIMITED — $1.6M (2.9% market share); 4. S K AGE EXPORTS — $1.2M (2.2% market share); 5. MEDOPHARM — $1.1M (2.1% market share). Together they account for 84.1% of India's total sulfadoxine export value.

Q: What is the total export value of sulfadoxine from India?

The total export value of sulfadoxine from India is $54.0M USD, recorded across 364 shipment transactions from 41 active exporters to 38 destination countries. The average shipment value is $148.4K.

Q: Which countries import sulfadoxine from India?

India exports sulfadoxine to 38 countries worldwide. The top importing countries are: NIGERIA (27.3% share, $14.8M), CHAD (14.2% share, $7.7M), BURKINA FASO (13.1% share, $7.0M), PAPUA NEW GUINEA (7.2% share, $3.9M), SENEGAL (6.4% share, $3.5M). These five markets account for 68.2% of total export value.

Q: What is the HS code for sulfadoxine exports from India?

The primary HS code for sulfadoxine exports from India is 30046000. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of sulfadoxine exports from India?

The average unit price for sulfadoxine exports from India is $15.97 USD per unit, with prices ranging from $0.04 to $269.91 depending on formulation, packaging, and order volume. The total market is valued at $54.0M across 364 shipments.

Q: Which ports handle sulfadoxine exports from India?

The primary ports for sulfadoxine exports from India are NHAVA SHEVA SEA (INNSA1) (19.0% of shipments), JNPT/ NHAVA SHEVA SEA (14.0% of shipments), JNPT (10.2% of shipments), NHAVA SHEVA (8.8% of shipments), PATLI ICD (INPTL6) (5.5% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of sulfadoxine?

India is one of the world's leading exporters of sulfadoxine due to its large base of 41 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports sulfadoxine to 38 countries, demonstrating 19% global market coverage.

Q: What certifications do Indian sulfadoxine exporters need?

Indian sulfadoxine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import sulfadoxine from India?

There are 74 registered buyers importing sulfadoxine from India, spread across 38 countries. The repeat buyer rate is 55.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top sulfadoxine supplier from India?

S KANT HEALTHCARE LIMITED is the leading sulfadoxine exporter from India with a market share of 69.5% and total export value of $37.5M across 103 shipments. The top 5 suppliers together control 84.1% of total export value.

Suresh Sormare

Sulfadoxine

India Pharmaceutical Trade Intelligence

$54.0M41 Suppliers38 CountriesHS 30046000

ExportsIndia → NIGERIA27.3%India → CHAD14.2%

ImportsCHINA → India$1.7K

#1 Supplier: S KANT #1 Buyer: ERRA

Sulfadoxine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Sulfadoxine to the World

Between 2022 and 2026, India exported $54.0M worth of sulfadoxine across 364 verified shipments to 38 countries — covering 19% of world markets in the Antimalarial & Antiparasitic segment. The largest destination is NIGERIA (27.3%). S KANT HEALTHCARE LIMITED leads with a 69.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Sulfadoxine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Sulfadoxine export data snapshot — $54.0M · 41 exporters · 38 countriesTransData Nexus · Indian Customs Data

Top Sulfadoxine Exporters from India

41 active exporters · Ranked by export value

View all 41 →

Top Sulfadoxine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	S KANT HEALTHCARE LIMITED	$37.5M	103	18	69.5%
2	MACLEODS PHARMACEUTICALS LTD

Top Countries Importing Sulfadoxine from India

38 destination markets · Ranked by import value

All 38 countries →

Top Countries Importing Sulfadoxine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	NIGERIA	$14.8M	27.3%
2	CHAD	$7.7M	14.2%
3	BURKINA FASO	$7.0M	13.1%
4	PAPUA NEW GUINEA	$3.9M	7.2%
5	SENEGAL	$3.5M	6.4%
6	MOZAMBIQUE	$3.2M	5.8%
7	COTE D IVOIRE	$2.3M	4.2%
8	GUINEA	$1.8M	3.3%
9	BELGIUM	$1.6M	2.9%
10	CONGO DR	$1.2M	2.3%

NIGERIA is India's largest sulfadoxine export destination, absorbing 27.3% of total exports worth $14.8M. The top 5 importing countries — NIGERIA, CHAD, BURKINA FASO, PAPUA NEW GUINEA, SENEGAL — together account for 68.2% of India's total sulfadoxine export value. The remaining 33 destination countries collectively receive the other 31.8%, indicating a focused distribution strategy targeting key markets.

Who Supplies Sulfadoxine to India?

1 origin countries · Total import value: $1.7K

India imports sulfadoxine from 1 countries with a combined import value of $1.7K. The largest supplier is CHINA ($1.7K, 3 shipments), followed by . All values are from Indian Customs (DGFT) import records.

Countries Supplying Sulfadoxine to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	CHINA	$1.7K	3	100.0%

CHINA is the largest supplier of sulfadoxine to India, accounting for 100.0% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Sulfadoxine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, sulfadoxine is not listed as an approved standalone product in the FDA's Orange Book. However, it is commonly used in combination with pyrimethamine as an antimalarial treatment. The absence of approved Abbreviated New Drug Applications (ANDAs) for sulfadoxine alone indicates limited direct market presence in the United States. This aligns with the export data, which shows no significant shipments of sulfadoxine from India to the U.S. market during the 2022-2026 period.

2EU & UK Regulatory Framework

In the European Union and the United Kingdom, sulfadoxine is utilized in combination therapies for malaria treatment. Medicinal products containing sulfadoxine require marketing authorization from the European Medicines Agency (EMA) or the UK's Medicines and Healthcare products Regulatory Agency (MHRA). Manufacturers must comply with Good Manufacturing Practice (GMP) standards as outlined in Directive 2001/83/EC, which mandates that no medicinal product may be placed on the market without proper authorization. (ema.europa.eu)

3WHO Essential Medicines & Global Standards

Sulfadoxine, in combination with pyrimethamine, is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in treating malaria. The combination is also subject to WHO Prequalification, ensuring that products meet global standards for quality, safety, and efficacy. Pharmacopoeial standards for sulfadoxine are detailed in the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), providing comprehensive guidelines for its quality and formulation.

4India Regulatory Classification

In India, sulfadoxine is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, sulfadoxine is not listed under the Drugs (Prices Control) Order (DPCO), suggesting no specific ceiling price is imposed. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceutical products, ensuring compliance with international standards and regulations.

5Patent & Exclusivity Status

Sulfadoxine's primary patents have expired, allowing for generic production and competition. This has led to a diversified market with multiple manufacturers, as evidenced by the 41 active Indian exporters during the 2022-2026 period. The average Free on Board (FOB) unit price of $15.97 reflects this competitive landscape.

6Recent Industry Developments

In June 2025, the WHO updated its malaria treatment guidelines, emphasizing the use of sulfadoxine-pyrimethamine in intermittent preventive treatment during pregnancy (IPTp) to reduce maternal and neonatal morbidity. In September 2025, the EMA granted orphan designation to a new antimalarial combination therapy, potentially impacting the market dynamics for existing treatments like sulfadoxine-pyrimethamine. In December 2025, the NPPA conducted a review of essential medicines pricing, though sulfadoxine remained unaffected due to its exclusion from the DPCO list. In February 2026, the CDSCO issued a directive enhancing quality control measures for antimalarial drugs, including sulfadoxine combinations, to ensure compliance with international standards. In March 2026, the DGFT streamlined the export NOC process for pharmaceuticals, aiming to facilitate faster approvals for exporters of sulfadoxine and other essential medicines.

These developments reflect the evolving regulatory landscape for sulfadoxine, highlighting its continued relevance in global malaria treatment protocols and the importance of compliance with international quality and safety standards.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Sulfadoxine

Retail & reference prices across 9 markets vs. India FOB export price of $15.97/unit

Global Price Benchmark for Sulfadoxine across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	N/A	USD	Sulfadoxine-pyrimethamine is not commonly used in the U.S. for malaria treatment; therefore, specific pricing data is limited.
United Kingdom	N/A	GBP	The National Health Service (NHS) Drug Tariff does not list sulfadoxine-pyrimethamine, indicating limited use and availability.
Germany	N/A	EUR	The German Federal Institute for Drugs and Medical Devices (BfArM) does not list sulfadoxine-pyrimethamine, suggesting limited availability.
Australia

Supply Chain Risk Assessment — Sulfadoxine

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Sulfadoxine, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. This dependency has been highlighted during periods of supply disruptions. For instance, in 2018, environmental regulations led to the shutdown of several Chinese API manufacturers, causing supply shortages and price escalations for Indian pharmaceutical companies. Such events underscore the vulnerability of India's pharmaceutical supply chain to external factors affecting Chinese production.

The Indian government has recognized this risk and, in March 2020, introduced the Production Linked Incentive (PLI) scheme to bolster domestic API manufacturing. This initiative aims to reduce reliance on imports by incentivizing local production of critical APIs and KSMs. However, the effectiveness of this scheme in achieving self-sufficiency remains to be fully realized, and the industry continues to monitor its progress closely.

2Supplier Concentration & Single-Source Risk

The Sulfadoxine export market from India exhibits significant supplier concentration, with the top five exporters controlling 84.1% of the market. S KANT HEALTHCARE LIMITED alone accounts for 69.5% of exports, indicating a heavy reliance on a single supplier. Such concentration poses risks, as any operational disruptions within these key companies could lead to substantial supply shortages.

Access Complete Sulfadoxine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 364 transactions across 38 markets.

Request Demo View Pricing

Frequently Asked Questions — Sulfadoxine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top sulfadoxine exporters from India?

The leading sulfadoxine exporters from India are S KANT HEALTHCARE LIMITED, MACLEODS PHARMACEUTICALS LTD, GRACURE PHARMACEUTICALS LIMITED, and 8 others. S KANT HEALTHCARE LIMITED leads with 69.5% market share ($37.5M). The top 5 suppliers together control 84.1% of total export value.

What is the total export value of sulfadoxine from India?

The total export value of sulfadoxine from India is $54.0M, recorded across 364 shipments from 41 active exporters to 38 countries. The average shipment value is $148.4K.

Which countries import sulfadoxine from India?

India exports sulfadoxine to 38 countries. The top importing countries are NIGERIA (27.3%), CHAD (14.2%), BURKINA FASO (13.1%), PAPUA NEW GUINEA (7.2%), SENEGAL (6.4%), which together account for 68.2% of total export value.

What is the HS code for sulfadoxine exports from India?

The primary HS code for sulfadoxine exports from India is 30046000. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Sulfadoxine

Sulfadoxine

Top Sulfadoxine Exporters from India

Top Countries Importing Sulfadoxine from India

Who Supplies Sulfadoxine to India?

Quick Facts

Related Antimalarial & Antiparasitic

Related Analysis

Need Details?

Regulatory Landscape — Sulfadoxine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Sulfadoxine

Supply Chain Risk Assessment — Sulfadoxine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Sulfadoxine Trade Intelligence

Frequently Asked Questions — Sulfadoxine Exports from India

Who are the top sulfadoxine exporters from India?

What is the total export value of sulfadoxine from India?

Which countries import sulfadoxine from India?

What is the HS code for sulfadoxine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of sulfadoxine exports from India?

Which ports handle sulfadoxine exports from India?

Why is India a leading exporter of sulfadoxine?

What certifications do Indian sulfadoxine exporters need?

How many buyers import sulfadoxine from India?

What is the market share of the top sulfadoxine exporter from India?

Analysis Methodology